Jouaville L F, Annesi-Maesano I, Nguyen L T, Bocage A S, Bedu M, Caillaud D
Physiology and Pulmonary Department, Clermont-Ferrand, France.
Clin Exp Allergy. 2003 Nov;33(11):1506-11. doi: 10.1046/j.1365-2222.2003.01800.x.
Exhaled nitric oxide (eNO) has attracted increasing interest as a non-invasive marker of airway inflammation in asthma. However, little evidence exists on the influences exerted on eNO by the interrelations among atopic status, asthma and rhinitis.
Among the 1156 children who participated in a large-scale epidemiological survey on asthma and allergies (ISAAC II: International Study of Asthma and Allergies in Childhood Phase II) in the city of Clermont-Ferrand, 53 asthmatics without corticosteroid treatment and 96 non-asthmatics were invited to perform eNO and skin prick tests (SPTs) to 12 common allergens.
Atopic asthmatic children had higher eNO than non-atopic asthmatic children (28.9+/-9.1 vs. 17.1+/-13.1 p.p.b.; P=0.0004) with a significant increase when one SPT or more are positive (26.5+/-7.8 vs. 17.1+/-13.1 p.p.b.; P=0.03). Similarly, non-asthmatic, atopic subjects had higher eNO than non-atopic subjects with a significant increase when two SPTs or more are positive (19.4+/-9.8 vs. 11.7 +/-6.7 p.p.b.; P=0.003). In the case of equal levels of positive SPTs (0, 1, >/=2), asthmatic children always had higher eNO than non-asthmatic ones. Furthermore, among non-asthmatic children, the eNO level increased only in atopics who had rhinitis (20.7+/-13 vs. 12.5+/-6.4 p.p.b. in atopic controls (subjects without rhinitis and asthma) and 12.3+/-6.6 p.p.b. in non-atopic controls; P=0.001), whereas among asthmatic children, eNO level increased in atopics independently of rhinitis (28.2+/-9.5 p.p.b. in those with rhinitis and 30.9+/-8.1 p.p.b. in those without) as well as in non-atopics with rhinitis (22.5+/-17.2 p.p.b.).
Our data suggest that besides atopy and asthma, allergic rhinitis should also be taken into account in the assessment of eNO.
呼出一氧化氮(eNO)作为哮喘气道炎症的一种非侵入性标志物,已引起越来越多的关注。然而,关于特应性状态、哮喘和鼻炎之间的相互关系对eNO的影响,目前证据较少。
在参与克莱蒙费朗市哮喘和过敏大规模流行病学调查(国际儿童哮喘和过敏研究II期:ISAAC II)的1156名儿童中,邀请了53名未接受皮质类固醇治疗的哮喘患儿和96名非哮喘患儿进行eNO检测以及针对12种常见变应原的皮肤点刺试验(SPT)。
特应性哮喘患儿的eNO水平高于非特应性哮喘患儿(28.9±9.1对17.1±13.1 ppb;P = 0.0004),当一项或多项SPT呈阳性时,eNO水平显著升高(26.5±7.8对17.1±13.1 ppb;P = 0.03)。同样,非哮喘的特应性受试者的eNO水平高于非特应性受试者,当两项或更多项SPT呈阳性时,eNO水平显著升高(19.4±9.8对11.7±6.7 ppb;P = 0.003)。在SPT阳性水平相同(0、1、≥2)的情况下,哮喘患儿的eNO水平始终高于非哮喘患儿。此外,在非哮喘儿童中,仅患有鼻炎的特应性儿童的eNO水平升高(20.7±13,特应性对照(无鼻炎和哮喘的受试者)为12.5±6.4 ppb,非特应性对照为12.3±6.6 ppb;P = 0.001),而在哮喘儿童中,无论是否患有鼻炎,特应性儿童的eNO水平均升高(患有鼻炎的儿童为28.2±9.5 ppb,未患鼻炎的儿童为30.9±8.1 ppb),患有鼻炎的非特应性儿童的eNO水平也升高(22.5±17.2 ppb)。
我们的数据表明,除了特应性和哮喘外,在评估eNO时还应考虑过敏性鼻炎。